Pulmonary, Critical Care Medicine, and Sleep Medicine, Department of Internal Medicine, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.
Rev Med Virol. 2024 Nov;34(6):e70005. doi: 10.1002/rmv.70005.
Influenza A virus (IAV) remains a significant global public health threat, causing substantial illness and economic burden. Despite existing antiviral drugs, the emergence of resistant strains necessitates alternative therapeutic strategies. This review explores the complex interplay between the ubiquitin proteasome system (UPS) and IAV pathogenesis. We discuss how IAV manipulates the UPS to promote its lifecycle, while also highlighting how host cells utilise the UPS to counteract viral infection. Recent research on deubiquitinases as potential regulators of IAV infection is also addressed. By elucidating the multifaceted role of the UPS in IAV pathogenesis, this review aims to identify potential targets for novel therapeutic interventions.
甲型流感病毒(IAV)仍然是一个重大的全球公共卫生威胁,导致大量疾病和经济负担。尽管存在抗病毒药物,但耐药株的出现需要替代治疗策略。本综述探讨了泛素蛋白酶体系统(UPS)与 IAV 发病机制之间的复杂相互作用。我们讨论了 IAV 如何操纵 UPS 以促进其生命周期,同时还强调了宿主细胞如何利用 UPS 来抵抗病毒感染。还讨论了最近关于去泛素化酶作为 IAV 感染的潜在调节剂的研究。通过阐明 UPS 在 IAV 发病机制中的多方面作用,本综述旨在确定新型治疗干预的潜在靶点。